查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
第一代細胞的全球市場 - 規模，佔有率，趨勢分析，機會，預測:來源，各類型，各終端用戶，各地區(2019年～2029年)
市場調查報告書
商品編碼
1249977

第一代細胞的全球市場 - 規模，佔有率，趨勢分析，機會，預測:來源，各類型，各終端用戶，各地區(2019年～2029年)

Primary Cells Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Origin ; By Type ; By End User ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球第一代細胞的市場規模，從2022年的42億9,000萬美元到2029年預計達到86億美元，在2023年～2029年的預測期間內11.6％的年複合成長率大幅度成長。市場主要成長要素，是癌症的發生率增加，癌症研究的政府輔助擴大，支撐醫療產業的基礎設施擴大等。

本報告提供全球第一代細胞市場相關相關分析，提供市場規模與預測，市場區隔分析，地區分析，企業簡介等資訊。

目錄

第1章 調查架構

第2章 摘要整理

第3章 全球第一代細胞市場考察

  • 產業價值鏈分析
  • DROC分析
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
  • 技術的進步/最近的發展
  • 法律規範
  • 波特的五力分析

第4章 全球第一代細胞市場概要

  • 市場規模與預測(2019年～2029年)
    • 金額
  • 市場佔有率與預測
    • 各來源
      • 人第一代細胞
      • 動物第一代細胞
    • 各類型
      • 造血細胞
      • 皮膚細胞
      • 消化管細胞
      • 肝細胞
      • 其他(肺細胞，腎細胞，心臟細胞，肌肉骨骼細胞，第一代細胞)
    • 各終端用戶
      • 生命科學研究企業
      • 研究機關
    • 各地區
      • 北美
      • 歐洲
      • 亞太地區
      • 南美
      • 中東、非洲

第5章 北美的第一代細胞市場

  • 市場規模與預測(2019年～2029年)
    • 金額
  • 市場佔有率與預測
    • 各來源
    • 各類型
    • 各終端用戶
    • 各國
      • 美國
      • 加拿大

第6章 歐洲的第一代細胞市場

  • 市場規模與預測(2019年～2029年)
    • 金額
  • 市場佔有率與預測
    • 各來源
    • 各類型
    • 各終端用戶
    • 各國
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 其他的歐洲

第7章 亞太地區的第一代細胞市場

  • 市場規模與預測(2019年～2029年)
    • 金額
  • 市場佔有率與預測
    • 各來源
    • 各類型
    • 各終端用戶
    • 各國
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳洲、紐西蘭
      • 印尼
      • 馬來西亞
      • 新加坡
      • 越南
      • 其他的亞太地區

第8章 南美的第一代細胞市場

  • 市場規模與預測(2019年～2029年)
    • 金額
  • 市場佔有率與預測
    • 各來源
    • 各類型
    • 各終端用戶
    • 各國
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其他的南美

第9章 中東、非洲的第一代細胞市場

  • 市場規模與預測(2019年～2029年)
    • 金額
  • 市場佔有率與預測
    • 各來源
    • 各類型
    • 各終端用戶
    • 各國
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • 其他的中東、非洲

第10章 競爭情形

  • 主要企業與其產品的清單
  • 全球第一代細胞企業的市場佔有率分析(2022年)
  • 競爭基準:各經營參數
  • 主要策略的展開(合併，收購，夥伴關係等)

第11章 COVID-19對全球第一代細胞市場的影響

第12章 企業簡介(企業概要，財務矩陣，競爭情形，主要的人力資源，主要的競爭，聯絡處，策略性預測，SWOT分析)

  • Thermo Fisher Scientific Inc
  • Merck Group
  • Lonza
  • Cell Biologics, Inc.
  • PromoCell-Human Centered Science
  • ZenBio, Inc.
  • STEMCELL Technologies Inc
  • AllCells
  • 其他的著名企業

第13章 主要策略的推薦事項

第14章 調查手法

簡介目錄
Product Code: BWC23223

Global Primary Cells Market Size Doubles to Reach USD 8.6 Billion by 2029.

Global primary cells market is flourishing because of increasing adoption of technology advancements and growing cancer research and development.

BlueWeave Consulting, a leading strategic consulting and Market research firm, in its recent study, estimated global primary cells market size at USD 4.29 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global primary cells market size to grow at a significant CAGR of 11.6% reaching a value of USD 8.6 billion by 2029. Major growth factors of global primary cells market include an increasing incidence of cancer, growing government support for cancer research, and expanding infrastructure to support the healthcare industry. The growing prevalence of chronic diseases worldwide, such as cancer, infections, autoimmune disorders, diabetes, and cardiovascular diseases, is a significant contributor to the growth of the primary cell market. It has also led to a rise in research activities for advanced therapies. The use of primary cell cultures for drug screening and in-vitro testing is also becoming increasingly popular, contributing to the growth of the primary cell market. The global primary cells market is being driven by advancements in genetic engineering and increased funding for research into cellular treatments. However, concerns regarding primary cell culture contamination are anticipated to restrain the overall market growth during the period in analysis.

Global Primary Cells Market - Overview:

The primary cells market refers to the market for primary cells, which are cells that have been freshly isolated from living tissues or organs, typically from humans or animals. These cells are used for research purposes, including drug discovery and development, toxicology testing, and basic research. Primary cells are important tools for studying biological processes and diseases, and they are widely used in both academic and commercial research settings. The primary cells market includes the production, distribution, and sale of primary cells, as well as related products and services such as cell culture media, reagents, and cell isolation kits.

Impact of COVID-19 on Global Primary Cells Market

COVID-19 had a positive impact on primary cell market. Primary cell culture is being used by researchers to better understand the infection and build standardized epithelial cell culture models. These models can assist duplicate the features of the respiratory tract, perhaps leading to breakthrough scientific findings with medical applications. In addition, the identification of primary cells for the treatment of many diseases is expanding. Due to their increased use in a variety of healthcare applications, private associations, biotech businesses, and government agencies have increased their interest and investment in this area. The growing utilization of primary cell cultures for viral synthesis, which is then used to make numerous vaccines, is also projected to move the market ahead.

Global Primary Cells Market - By Region:

Global primary cells market covers five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America held the highest share of revenue in the primary cell culture market and this trend is expected to continue throughout the forecast period. The growth in the region's market can be attributed to factors such as the high cost of healthcare, the increasing elderly population, the rising prevalence of chronic illnesses, and government funding support. Furthermore, the market in the region is expanding due to the focus of market players on developing innovative cell culture applications, improved instrumentation, a wide range of cell types, and the study of their cellular interactions.

Competitive Landscape

Major players operating in global primary cells market include Thermo Fisher Scientific Inc, Merck Group, Lonza, Cell Biologics, Inc., PromoCell - Human Centered Science, ZenBio, Inc., STEMCELL Technologies Inc, and AllCells. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Primary Cells Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Global Primary Cells Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the Market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Primary Cells Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Cancer Research
      • 3.2.1.2. Advancement in Technologies
    • 3.2.2. Restraints
      • 3.2.2.1. Concern Regarding Primary Cell Culture Contamination
    • 3.2.3. Opportunities
      • 3.2.3.1. Advancing Biomedical Research Using Primary Cells in 3D Cultures
    • 3.2.4. Challenges
      • 3.2.4.1. Impact on Supply Chain Due to Covid
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Primary Cells Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Origin
      • 4.2.1.1. Human Primary Cells
      • 4.2.1.2. Animal Primary Cells
    • 4.2.2. By Type
      • 4.2.2.1. Hematopoietic Cells
      • 4.2.2.2. Dermatocytes
      • 4.2.2.3. Gastrointestinal Cells
      • 4.2.2.4. Hepatocytes
      • 4.2.2.4.1. Cryopreserved Hepatocytes
      • 4.2.2.4.2. Fresh Hepatocytes
      • 4.2.2.5. Others (Lung Cells, Renal Cells, Heat Cells, Musculoskeletal Cells, Primary Cells)
    • 4.2.3. By End User
      • 4.2.3.1. Life Science Research Companies
      • 4.2.3.2. Research Institutes
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Primary Cells Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Origin
    • 5.2.2. By Type
    • 5.2.3. By End User
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Origin
      • 5.2.4.1.2. By Type
      • 5.2.4.1.3. By End User
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Origin
      • 5.2.4.2.2. By Type
      • 5.2.4.2.3. By End User

6. Europe Primary Cells Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Origin
    • 6.2.2. By Type
    • 6.2.3. By End User
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Origin
      • 6.2.4.1.2. By Type
      • 6.2.4.1.3. By End User
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Origin
      • 6.2.4.2.2. By Type
      • 6.2.4.2.3. By End User
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Origin
      • 6.2.4.3.2. By Type
      • 6.2.4.3.3. By End User
      • 6.2.4.4. France
      • 6.2.4.4.1. By Origin
      • 6.2.4.4.2. By Type
      • 6.2.4.4.3. By End User
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Origin
      • 6.2.4.5.2. By Type
      • 6.2.4.5.3. By End User
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Origin
      • 6.2.4.6.2. By Type
      • 6.2.4.6.3. By End User
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Origin
      • 6.2.4.7.2. By Type
      • 6.2.4.7.3. By End User
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Origin
      • 6.2.4.8.2. By Type
      • 6.2.4.8.3. By End User
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Origin
      • 6.2.4.9.2. By Type
      • 6.2.4.9.3. By End User

7. Asia-Pacific Primary Cells Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Origin
    • 7.2.2. By Type
    • 7.2.3. By End User
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Origin
      • 7.2.4.1.2. By Type
      • 7.2.4.1.3. By End User
      • 7.2.4.2. India
      • 7.2.4.2.1. By Origin
      • 7.2.4.2.2. By Type
      • 7.2.4.2.3. By End User
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Origin
      • 7.2.4.3.2. By Type
      • 7.2.4.3.3. By End User
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Origin
      • 7.2.4.4.2. By Type
      • 7.2.4.4.3. By End User
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Origin
      • 7.2.4.5.2. By Type
      • 7.2.4.5.3. By End User
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Origin
      • 7.2.4.6.2. By Type
      • 7.2.4.6.3. By End User
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Origin
      • 7.2.4.7.2. By Type
      • 7.2.4.7.3. By End User
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Origin
      • 7.2.4.8.2. By Type
      • 7.2.4.8.3. By End User
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Origin
      • 7.2.4.9.2. By Type
      • 7.2.4.9.3. By End User
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Origin
      • 7.2.4.10.2. By Type
      • 7.2.4.10.3. By End User

8. Latin America Primary Cells Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Origin
    • 8.2.2. By Type
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Origin
      • 8.2.4.1.2. By Type
      • 8.2.4.1.3. By End User
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Origin
      • 8.2.4.2.2. By Type
      • 8.2.4.2.3. By End User
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Origin
      • 8.2.4.3.2. By Type
      • 8.2.4.3.3. By End User
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Origin
      • 8.2.4.4.2. By Type
      • 8.2.4.4.3. By End User
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Origin
      • 8.2.4.5.2. By Type
      • 8.2.4.5.3. By End User

9. Middle East & Africa Primary Cells Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Origin
    • 9.2.2. By Type
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Origin
      • 9.2.4.1.2. By Type
      • 9.2.4.1.3. By End User
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Origin
      • 9.2.4.2.2. By Type
      • 9.2.4.2.3. By End User
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Origin
      • 9.2.4.3.2. By Type
      • 9.2.4.3.3. By End User
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Origin
      • 9.2.4.4.2. By Type
      • 9.2.4.4.3. By End User
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Origin
      • 9.2.4.5.2. By Type
      • 9.2.4.5.3. By End User
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Origin
      • 9.2.4.6.2. By Type
      • 9.2.4.6.3. By End User
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Origin
      • 9.2.4.7.2. By Type
      • 9.2.4.7.3. By End User
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Origin
      • 9.2.4.8.2. By Type
      • 9.2.4.8.3. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Primary Cells Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Primary Cells Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Thermo Fisher Scientific Inc
  • 12.2. Merck Group
  • 12.3. Lonza
  • 12.4. Cell Biologics, Inc.
  • 12.5. PromoCell - Human Centered Science
  • 12.6. ZenBio, Inc.
  • 12.7. STEMCELL Technologies Inc
  • 12.8. AllCells
  • 12.9. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations